Scholarlink

<p>The production of aminoglycoside-modifying genes by <i>P. aeruginosa</i> is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples. A total of 500 clinical samples were collected from Khyber Teaching Hospital (KTH), and showed a prevalence of 43.8% for <i>P. aeruginosa</i>. The biochemical identification of isolates was performed by Analytical Profile Index kit (API 20E) and on molecular level by PCR for the <i>OprL</i> gene. The antibiotic susceptibility pattern of the identified isolates was determined by the following guidelines of Clinical and Laboratory Standards Institute (CLSI), 2021. The results revealed that 121 out of 219 <i>P. aeruginosa</i> isolates were resistant to aminoglycosides. The frequencies of aac(6)-Ib, aac(3)-IIa and aac(6)-IIa were 95, 71.9, and 60.33%, respectively. Among the aminoglycoside-resistant isolates, 41.32% showed the presence of all the three genes. After sequencing of the PCR products, mutations were detected in aac(6)-Ib (Q110H), aac(3)-IIa (W5F, M51T, M58K, G63S) and aac(6)-IIa (T75P, G89S). The mutated sequence was translated into a protein sequence, followed by the prediction of its structure. After structure prediction, the binding ability of the wild and mutated proteins was analyzed through molecular docking. The docking analysis calculated different binding energy scores of -7.6, -7.1, -8.3, -7.1, and -7.1&#xa0;kcal/mol for the aac(6)-Ib wild protein and antibiotics, including Gentamicin, Tobramycin, Amikacin, Kanamycin, and Streptomycin, respectively. In the case of mutated proteins and antibiotics, binding energies of -6.8, -6.1, -7.3, -6, and -5.6&#xa0;kcal/mol were calculated. The dynamic stability of the docked complex was examined using molecular dynamics simulations, and the results indicate that the docked complexes maintain their stability throughout the simulation time frame.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Molecular and Computational Insights of Novel Mutations in Aminoglycoside-Modifying Genes of P. aeruginosa

  • 期刊论文

  • 发表日期：

    2025年9月3日

查看全文
  • Huma Jalil,
  • Khadija Shams,
  • Asad Ullah,
  • Ibrar Khan,
  • Sajjad Ahmad,
  • Ayesha Saleem,
  • Kalsoom Khan,
  • Muhammad Salim,
  • Syed Ainul Abideen,
  • Mohammad Abdullah Aljasir,
  • Muhammad Irfan

摘要

The production of aminoglycoside-modifying genes by P. aeruginosa is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples. A total of 500 clinical samples were collected from Khyber Teaching Hospital (KTH), and showed a prevalence of 43.8% for P. aeruginosa. The biochemical identification of isolates was performed by Analytical Profile Index kit (API 20E) and on molecular level by PCR for the OprL gene. The antibiotic susceptibility pattern of the identified isolates was determined by the following guidelines of Clinical and Laboratory Standards Institute (CLSI), 2021. The results revealed that 121 out of 219 P. aeruginosa isolates were resistant to aminoglycosides. The frequencies of aac(6)-Ib, aac(3)-IIa and aac(6)-IIa were 95, 71.9, and 60.33%, respectively. Among the aminoglycoside-resistant isolates, 41.32% showed the presence of all the three genes. After sequencing of the PCR products, mutations were detected in aac(6)-Ib (Q110H), aac(3)-IIa (W5F, M51T, M58K, G63S) and aac(6)-IIa (T75P, G89S). The mutated sequence was translated into a protein sequence, followed by the prediction of its structure. After structure prediction, the binding ability of the wild and mutated proteins was analyzed through molecular docking. The docking analysis calculated different binding energy scores of -7.6, -7.1, -8.3, -7.1, and -7.1 kcal/mol for the aac(6)-Ib wild protein and antibiotics, including Gentamicin, Tobramycin, Amikacin, Kanamycin, and Streptomycin, respectively. In the case of mutated proteins and antibiotics, binding energies of -6.8, -6.1, -7.3, -6, and -5.6 kcal/mol were calculated. The dynamic stability of the docked complex was examined using molecular dynamics simulations, and the results indicate that the docked complexes maintain their stability throughout the simulation time frame.